MarketWatch News on INO
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 11:09 a.m. Oct. 13, 2014 - The Trading Deck
Number of companies fighting Ebola grows, one wins fed OK 3:09 p.m. Oct. 6, 2014 - Russ Britt
The bottom of a capitulation barrel and the test tubes that say keep buying 7:56 a.m. Oct. 2, 2014 - Barbara Kollmeyer
Inovio shares climb 8% on report to advance Ebola trial 10:45 a.m. Sept. 24, 2014 - Ciara Linnane
Inovio, GeneOne to move Ebola vaccine to human trials 10:43 a.m. Sept. 24, 2014 - Erin McCarthy
Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Loading more headlines...
Advertisement
Other News on INO
Jim Cramer Talks About Verizon, Fiat Chrysler And Inovio Pharmaceuticals 6:42 a.m. Nov. 12, 2014 - benzinga.com
Cramer's Mad Money - The Hottest Stock You've Never Heard Of (11/11/14) 5:20 a.m. Nov. 12, 2014 - Seeking Alpha
Inovio Pharmaceuticals' (INO) CEO Joseph Kim on Q3 2014 Results - Earnings Call Transcript 1:14 p.m. Nov. 10, 2014 - Seeking Alpha
4 Stocks to Look at via Ebola Crisis - Analyst Blog 10:43 a.m. Nov. 10, 2014 - Zacks.com
10-Q: INOVIO PHARMACEUTICALS, INC. 6:03 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Inovio (INO) Disappoint Expectations for Q3 Earnings? - Analyst Blog 4:35 p.m. Nov. 7, 2014 - Zacks.com
Ebola Vaccine Contenders 9:44 a.m. Oct. 30, 2014 - benzinga.com
5 Stocks To Consider When Playing Ebola 11:31 a.m. Oct. 29, 2014 - Seeking Alpha
CDC issues new guidelines over Ebola 4:10 a.m. Oct. 28, 2014 - Seeking Alpha
Ebola Hits NYC: Time To Panic 8:45 a.m. Oct. 27, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/24/14 6:00 p.m. Oct. 24, 2014 - FOXBusiness
Mali confirms first Ebola case 4:48 a.m. Oct. 24, 2014 - Seeking Alpha
NYC doctor tests positive for Ebola; futures slip 9:57 p.m. Oct. 23, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:14 a.m. Oct. 21, 2014 - benzinga.com
US Stock Futures Gain After Strong Apple Results 6:17 a.m. Oct. 21, 2014 - benzinga.com
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog 2:34 p.m. Oct. 17, 2014 - Zacks.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/16/14 6:00 p.m. Oct. 16, 2014 - FOXBusiness
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on INO
Inovio to Present at Upcoming Investor Conferences 6:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics 9:05 a.m. Nov. 10, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Reports 2014 Third Quarter Financial Results 6:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014 6:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Critical Alerts For Mobileye NV, Schlumberger, Ambarella, Walter Energy and Inovio Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
The most undervalued, yet comprehensive cancer immunotherapy in development? 8:03 a.m. Nov. 3, 2014 - ACCESSWIRE
Inovio Pharmaceuticals' CEO Dr. J. Joseph Kim Interviewed by The Life Sciences Report 9:15 a.m. Oct. 30, 2014 - Marketwired
Time Magazine Warns Against Investing In Certain "Ebola Stocks" 9:22 a.m. Oct. 28, 2014 - ACCESSWIRE
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria 6:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 9:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
What's Next: Investors Place Ebola Pandemic Stock Bets 7:59 a.m. Oct. 6, 2014 - ACCESSWIRE
Critical Alerts For General Electric, Inovio Pharmaceuticals, Mylan, Rite Aid and Delta Airlines Released By InvestorsObserver 9:31 a.m. Oct. 3, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Appoints Vice President of Commercial Development 7:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science 6:00 a.m. Sept. 24, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 8:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Inovio to Present at Upcoming Investor Conferences 6:00 a.m. Sept. 18, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 8:59 a.m. Sept. 15, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to List on NASDAQ 9:00 a.m. Sept. 4, 2014 - PR Newswire - PRF
Inovio to Present at Upcoming Investor Conferences 8:00 a.m. Sept. 3, 2014 - PR Newswire - PRF
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
Loading more headlines...